Phase Ib Dose Escalation Study Of Oral Quisinostat, A Histone Deacetylase Inhibitor, In Combination With Bortezomib And Dexamethasone For Patients With Relapsed Multiple Myeloma

JOURNAL OF CLINICAL ONCOLOGY(2013)

引用 1|浏览14
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要